Amplify Transformational Data Sharing ETF vs Boston Scientific Corporation — how do they compare? Amplify Transformational Data Sharing ETF trades at $59.16, while Boston Scientific Corporation trades at $51.07 (market cap $74.19B). The key difference: Amplify Transformational Data Sharing ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BLOK | BSX | |
|---|---|---|
52-Week High | $74.10 | $108.14 |
52-Week Low | $47.36 | $42.63 |
Market Cap | — | $74.19B |
Sector | — | Health |
Enterprise Value | — | $86.27B |
Trailing returns across standard periods
Latest headlines on both assets
The fund is an actively managed ETF that seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of "transformational data sharing technologies". It may invest in non-US equity securities, including depositary receipts.
Read more on BLOK →Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →